BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 30338792)

  • 21. Yes! To Scaling Up Cervical Cancer Screening With Self-Collection: But the Cost of HPV Screening Must Be Reduced.
    Beddoe AM
    JCO Glob Oncol; 2021 Aug; 7():1327-1328. PubMed ID: 34436925
    [No Abstract]   [Full Text] [Related]  

  • 22. Value of TCT combined with serum CA153 and CA50 in early diagnosis of cervical cancer and precancerous lesions.
    Li H; Li L; Sun J; Dong S; Li H
    Pak J Med Sci; 2022; 38(6):1471-1476. PubMed ID: 35991263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the diagnostic value of Xpert HPV.
    Sabour S
    Lancet Glob Health; 2020 Aug; 8(8):e997. PubMed ID: 32710876
    [No Abstract]   [Full Text] [Related]  

  • 24. Assessing the diagnostic value of Xpert HPV - Authors' reply.
    Kuhn L; Saidu R; Denny L
    Lancet Glob Health; 2020 Aug; 8(8):e998. PubMed ID: 32710877
    [No Abstract]   [Full Text] [Related]  

  • 25. Microelectromechanical system-based diagnostic technology for cervical cancer.
    Gao S; Wang X
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1721-7. PubMed ID: 21850384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expressions of VEGF and miR-21 in tumor tissues of cervical cancer patients with HPV infection and their relationships with prognosis.
    Yuan Y; Min SJ; Xu DQ; Shen Y; Yan HY; Wang Y; Wang W; Tan YJ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6274-6279. PubMed ID: 30338794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Actinin-4 Levels as a Potential Diagnostic and Prognostic Marker in Cervical Cancer.
    Ma X; Xue H; Zhong J; Feng B; Zuo Y
    Dis Markers; 2020; 2020():5327378. PubMed ID: 32855746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cervical screening in HPV-vaccinated populations.
    Canfell K
    Climacteric; 2018 Jun; 21(3):227-234. PubMed ID: 29565690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
    Del Pino M; Alonso I; Rodriguez-Trujillo A; Bernal S; Geraets D; GuimerĂ  N; Torne A; Ordi J
    J Virol Methods; 2017 Oct; 248():238-243. PubMed ID: 28739302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on the value assessment of various screening programs regarding cervical cancer screening strategy in the rural areas of China].
    Li LY; Qiao ZQ; Zhang MF; Yang JP; Bao YP; An YT; Lei J; Xiong NH; Yu XH; Zhang X; Pan QJ; Qiao YL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):964-7. PubMed ID: 18399140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical diagnostic value of free body of reduced iron protoporphyrin in uterus epithelial cells on cervical carcinoma and precancerous lesion.
    Zhou X; Zuo JH; Wu ZY; Ma Y; Ou SR
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2145-2149. PubMed ID: 28537670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic accuracy of high-risk HPV DNA genotyping for primary cervical cancer screening and triage of HPV-positive women, compared to cytology: preliminary results of the PIPAVIR study.
    Chatzistamatiou K; Moysiadis T; Angelis E; Kaufmann A; Skenderi A; Jansen-Duerr P; Lekka I; Kilintzis V; Angelidou S; Katsiki E; Hagemann I; Tsertanidou A; Koch I; Boecher O; Soutschek E; Maglaveras N; Agorastos T
    Arch Gynecol Obstet; 2017 May; 295(5):1247-1257. PubMed ID: 28337594
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
    Ogilvie GS; Krajden M; van Niekerk D; Smith LW; Cook D; Ceballos K; Lee M; Gentile L; Gondara L; Elwood-Martin R; Peacock S; Stuart G; Franco EL; Coldman AJ
    Int J Cancer; 2017 Jan; 140(2):440-448. PubMed ID: 27685757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of FH detection combined with HPV screening on the diagnostic significance of cervical cancer and precancerous lesions.
    Hu YJ; Zhang HP; Zhu B; Chen HY; Ma LH; Wang Y
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6288-6293. PubMed ID: 30338792
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.